MGN-4893

DB17338ExperimentalNucleic Acid Based Therapies

MGN-4893 is an inhibitor of microRNA-451. In February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.

Code names
MGN-4893

What you can answer from here — as of April 02, 2025

1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of MGN-4893, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In